CAR T-cell therapy for relapsed or refractory mantle-cell lymphoma
- PMID: 32278358
- DOI: 10.1016/S1470-2045(20)30231-X
CAR T-cell therapy for relapsed or refractory mantle-cell lymphoma
Comment on
-
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.N Engl J Med. 2020 Apr 2;382(14):1331-1342. doi: 10.1056/NEJMoa1914347. N Engl J Med. 2020. PMID: 32242358 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
